Seth Harmon
Director of Finance/CFO presso VIRIDIAN THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Posizioni attive di Seth Harmon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 12/09/2023 | - |
| Director of Finance/CFO | 12/09/2023 | - | |
| Corporate Officer/Principal | 01/05/2023 | 12/09/2023 |
Storia della carriera di Seth Harmon
Precedenti posizioni note di Seth Harmon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIONTECH SE | Director of Finance/CFO | 01/05/2020 | 01/05/2023 |
| NEON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2017 | 01/05/2020 |
Formazione di Seth Harmon
| Bowdoin College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Germania | 2 |
Posizioni
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIONTECH SE | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Seth Harmon
- Esperienza
